Spore.Bio, launched in 2023, has raised a Series A funding of US$23m to develop its AI-driven technology for rapid bacterial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results